[Results of veno-venous shunt with arterialization of the liver (author's transl)].
Since 1968, arterialization of the liver with a portacaval shunt has been carried out in 82 patients for the treatment of portal hypertension caused by cirrhosis. Lethality in the first 4 weeks after operation was 19%. In 35 patients it is now over 5 years since the operation, 5 years survival being 46%. The general condition of these patients is remarkably good. The liver's detoxifying function has been preserved. Encephalopathy is rare. In cases of existing portacaval shunt arterialization can still be performed by way of the V. umbilicalis. The detoxifying function will improve after this.
D000293:Adolescent; D000328:Adult; D000368:Aged; D005500:Follow-Up Studies; D006501:Hepatic Encephalopathy / Q000453:epidemiology; D006801:Humans; D006975:Hypertension, Portal / Q000601:surgery; D007083:Iliac Artery / Q000601:surgery; D008105:Liver Cirrhosis, Biliary / Q000601:surgery; D008875:Middle Aged; D011167:Portacaval Shunt, Surgical / Q000379:methods*; D011169:Portal Vein / Q000601:surgery; D011183:Postoperative Complications / Q000401:mortality; D012501:Saphenous Vein / Q000637:transplantation; D014182:Transplantation, Autologous; D014471:Umbilical Veins / Q000601:surgery
13. Spätergebnisse nach veno-venösem Shunt mit gleichzeitiger Arterialisation